← Vir Biotechnology (VIR)

Vir Biotechnology SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

  • 4Nov. 16, 2026, 12:16 p.m. ETView on SEC.gov
  • 4Nov. 16, 2026, 12:15 p.m. ETView on SEC.gov
  • 424B5Nov. 16, 2026, 9:18 a.m. ETView on SEC.gov
  • 8-KNov. 13, 2026, 9:47 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Other events · Financial statements and exhibits

    AI summary, unreviewedVir Biotechnology prices 15,000,000-share public offering at $10.00 per share for $150 million gross proceeds

  • 424B5Nov. 13, 2026, 9:41 p.m. ETView on SEC.gov
  • 424B5Nov. 12, 2026, 4:16 p.m. ETView on SEC.gov
  • SCHEDULE 13GNov. 10, 2026, 9:35 a.m. ETView on SEC.gov
  • 8-KNov. 9, 2026, 8:31 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

    AI summary, unreviewedVir Biotechnology Phase 3 ECLIPSE 1 Hits Primary Endpoint at 44% Response, Key Secondary at 79% Undetectable Virus

  • SCHEDULE 13D/ANov. 6, 2026, 6:55 p.m. ETView on SEC.gov
  • 10-QNov. 4, 2026, 5:12 p.m. ETView on SEC.gov
  • 8-KNov. 4, 2026, 4:10 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedVir Biotechnology Q3 2026 EPS of -$0.57 beats -$0.75 consensus, but revenue of -$0.2 million misses $1.4 million estimate

  • 4Nov. 4, 2026, 2:56 p.m. ETView on SEC.gov
  • 4Oct. 28, 2026, 1:34 p.m. ETView on SEC.gov
  • 8-KOct. 28, 2026, 8:37 a.m. ETView on SEC.gov

    Departure/appointment of directors or officers

    AI summary, unreviewedVir Biotechnology Expands Board to Nine Members with Appointment of Suzanne Topalian, M.D.

  • SCHEDULE 13G/AOct. 27, 2026, 5:25 p.m. ETView on SEC.gov
  • 8-KOct. 14, 2026, 8:35 a.m. ETView on SEC.gov

    Unregistered sales of equity securities · Other events · Financial statements and exhibits

  • 8-KOct. 8, 2026, 8:38 a.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • 8-KOct. 1, 2026, 8:34 a.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits

  • 4Aug. 12, 2026, 2:30 p.m. ETView on SEC.gov
  • SCHEDULE 13GAug. 7, 2026, 11:10 a.m. ETView on SEC.gov
  • 10-QAug. 5, 2026, 5:20 p.m. ETView on SEC.gov
  • 8-KAug. 5, 2026, 4:09 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

  • SCHEDULE 13G/AJuly 31, 2026, 11:39 a.m. ETView on SEC.gov
  • 8-KJuly 24, 2026, 8:31 a.m. ETView on SEC.gov

    Departure/appointment of directors or officers